Financial Daily from THE HINDU group of publications
Sunday, Feb 29, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Lupin enters exclusive pact with Baxter for ceftriaxone injection

Our Bureau

Mumbai , Feb. 28

LUPIN Ltd on Saturday announced its second significant global announcement in less than a week.

The company has entered into an exclusive agreement with the US-based medical products company, Baxter Healthcare Corporation, to distribute the latter's generic version of ceftriaxone sterile vials for injection, in the US market.

Roche is the original patent holder and its product is marketed under the Rocephin brand name. Lupin said that the once-a-day dosing ceftriaxone injection is used to treat infections of the urinary tract, lower respiratory tract, meningitis, skin and skin structure, among others. Interestingly, the company's announcement followed a "premature leak" of the information, possibly as a result of computer-hacking..

Earlier this fiscal, Lupin had received the US Food and Drug Administration approval for its Abbreviated New Drug Application for ceftriaxone vials for injection 250 mg, 500 mg, 1g and 2g. The product would be manufactured at Lupin's plant in Mandideep, Madhya Pradesh — but the launch in the US would happen only after Roche's product patent expires in July 2005.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
ONGC's Seven Seas starts KG basin drilling


Shortage of coking coal — DPL plans to curtail production by 15 pc
Lupin enters exclusive pact with Baxter for ceftriaxone injection
Unichem Labs gets shareholders' nod for share-split, bonus
Preferential offers gain momentum
Ashok Leyland to spend Rs 650 cr on capacity expansion
Setback for Dr Reddy's as Pfizer wins ruling
Berger Intl income up 26.9 pc
Unclaimed fixed deposits — Companies favour quarterly transfer to Fund
Mascon okays rights issue
GM eyes higher market share for Optra
Multivac to earn Rs 60 cr from battery-operated vehicles



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line